Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Insider activity.

<< Previous

Bullboard Posts

Next >>

Comment by inthnoon Dec 12, 2024 10:47pm

103 Views

Post# 36360317

RE:RE:RE:RE:RE:RE:Insider activity.

Hey normy, yes I have a different alias on the other board, never denied it.
Good thing we have u here to add so much of your knowledge and wisdom for everyone.. as.for.misleading, it's all a matter of interpretation as u and others constantly applaud others who often mislead and give false hope but that is OK. Oh well is what it is and good to hear from you and nice to know u think the company is doing everyone favors even though they mislead us.

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season